malondialdehyde has been researched along with Lymphoma, Non-Hodgkin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akingbola, T; Akinlolu, A; Salau, B | 1 |
| Borodulin, VB; Chudilova, AV; Goroshinskaja, IA; Kachesova, PS; Nemashkalova, LA; Shalashnaja, EV | 1 |
2 other study(ies) available for malondialdehyde and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Lipid peroxidation in Nigerians affected with haematological malignancies.
Topics: Adult; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lipid Peroxidation; Lymphoma, Non-Hodgkin; Male; Malondialdehyde; Multiple Myeloma; Nigeria; Oxidative Stress; Prognosis | 2012 |
[Effect of iron nanoparticles on free radical oxidation process in blood of rats with Pliss lymphosarcoma].
Topics: Animals; Catalase; Ceruloplasmin; Free Radicals; Iron; Lymphoma, Non-Hodgkin; Male; Malondialdehyde; Metal Nanoparticles; Neoplasms, Experimental; Oxidation-Reduction; Rats | 2016 |